$19.54▴ 2.25%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+42.0%year over year
Strong
Revenue is growing strongly year over year.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Overvalued
Trading about 179% above our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Omada Health, Inc.'s earnings-quality signal is not available yet. Revenue is growing strongly year over year.
Key numbers
Valuation
EPS (TTM)$-0.09
TTM (trailing 12 months, through fiscal Q1 FY2026)
Profitability
Net margin-2.2%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$283.30M
TTM (trailing 12 months, through fiscal Q1 FY2026)
Recent news
Sentiment · last 30 days1 article
1 bullish0 neutral0 bearish
Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference
Omada Health CEO Sean Duffy Sells 17,000 Shares. What Does This Mean for Investors?Digital Health for the Musculoskeletal Care Market: 2026-2032 Outlook | Increasing Investment in Health and Fitness Apps Drives Adoption of Digital Health Solutions for Musculoskeletal Health Tracking
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.